Property | Value |
?:abstract
|
-
WHAT IS KNOWN AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) is associated with increased risk of venous thromboembolism (VTE) Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization CASE SUMMARIES: We present 5 patients hospitalized for COVID-19 while on DOACs Four patients had atrial fibrillation and had a previous VTE Four patients developed acute VTE and one developed stroke-like symptoms Monitoring D-dimer assisted with the detection of VTE Three patients died, and two were discharged alive WHAT IS NEW AND CONCLUSION: Therapeutic failure with DOACs appears to be commonplace in COVID-19 Further research is needed to determine whether there is an underlying cause to this association
|
is
?:annotates
of
|
|
?:creator
|
|
?:journal
|
|
?:license
|
|
?:publication_isRelatedTo_Disease
|
|
?:source
|
|
?:title
|
-
Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants
|
?:type
|
|
?:who_covidence_id
|
|
?:year
|
|